Citius Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
±-± -
Good morning, everyone, and welcome to the H.C. Wainwright 24th Annual Global Investment Hybrid Conference. My name is Lander, and I'm a Biotech Equity Research Associate at H.C. Wainwright. We're pleased to have you with us today, and it is now my pleasure to introduce our first presenter. Please join me in welcoming Leonard Mazur, CEO of Citius Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of critical care products. Leonard, please take it away.
Lander, thank you very much for the introduction. And also, I want to thank everybody that's here in person as well as those who are online with us. I want to thank you for taking the time out to be here with us. And also, just as an aside, I would also like to thank the New York City Port Authority and their bus system for the fact that I'm here because on my way
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |